A Diastereoselective Synthesis of Functionalized 3-Pyrazolidinones from ­Hydrazines, Aromatic Aldehydes, and Acylketene

Issa Yavari; Mohammad J. Bayat; Stavroula Skoulika

doi:10.1055/s-0033-1339642

Synlett, Inhaltsverzeichnis

Synlett 2013; 24(19): 2591-2595
DOI: 10.1055/s-0033-1339642

letter

A Diastereoselective Synthesis of Functionalized 3-Pyrazolidinones from Hydrazines, Aromatic Aldehydes, and Acylketene

Autoren

Issa Yavari*

^aDepartment of Chemistry, Tarbiat Modares University, PO Box 14115-175, Tehran, Iran Fax: +98(21)82883455 eMail: yavarisa@modares.ac.ir
Mohammad J. Bayat

^aDepartment of Chemistry, Tarbiat Modares University, PO Box 14115-175, Tehran, Iran Fax: +98(21)82883455 eMail: yavarisa@modares.ac.ir
Stavroula Skoulika

^bLaboratory of Physical Chemistry, Department of Chemistry, The University of Ioannina, 45110 Ioannina, Greece

Abstract

Alle Artikel dieser Rubrik

Abstract

A practical microwave-assisted, one-pot method for the construction of 4-acetyl-2-phenyl-5-aryl-3-pyrazolidinones via a tandem reaction between phenylhydrazine, aromatic aldehydes, and but-1-ene-1,3-dione (acylketene), in moderate to good yields, is reported. When methylhydrazine and 4-methylphenylhydrazine hydrochloride were used instead of phenylhydrazine, the reaction led to the formation of 3-oxobutanohydrazide derivatives.

Key words

hydrazines - aromatic aldehydes - 1,3-dioxinone - microwave irradiation - acylketene

Volltext

Referenzen

References and Notes
1 Claramunt RM, Elguero J. Org. Prep. Proc. Int. 1991; 23: 273
2 Rutjes FP. J. T, Udding JH, Hiemstra H, Speckamp WN. Heterocycles 1992; 33: 81
3 White JD, Toske SG. Bioorg. Med. Chem. Lett. 1993; 3: 2383
4 White JD, Toske SG. Tetrahedron Lett. 1993; 34: 207
5 Janin YL. Chem. Rev. 2012; 112: 3924
6 Fustero S, Sanchez-Rosello M, Barrio P, Simon-Fuentes A. Chem. Rev. 2011; 111: 6984
7 Varvounis G, Fiamegos Y, Pilidis G. Adv. Heterocycl. Chem. 2004; 87: 141
8 Presset M, Mohanan K, Hamann M, Coquerel Y, Rodriguez J. Org. Lett. 2011; 13: 4124
9 Gould E, Lebl T, Slawin MZ. A, Reid M, Smith AD. Tetrahedron 2010; 66: 8992
10 Sibi MP, Stanley LM, Nie X, Venkatraman L, Liu M, Jasperse CP. J. Am. Chem. Soc. 2007; 129: 395
11 Sibi MP, Soeta T. J. Am. Chem. Soc. 2007; 129: 4522
12 Yavari I, Nematpour M. Synlett 2012; 23: 165
13 Yavari I, Hosseinpour R, Pashazadeh R. Synlett 2012; 23: 1662
14 Yavari I, Khalili G, Sadeghizadeh F. Synlett 2012; 23: 557
15 Bell K, Sadasivam DV, Gudipati IR, Ji H, Birney D. Tetrahedron Lett. 2009; 50: 1295
16 Presset M, Coquerel Y, Rodriguez J. Org. Lett. 2010; 12: 4212
17 Tidwell TT. Ketenes II . Wiley-VCH; Weinheim: 2006
18 Fu N, Tidwell TT. Tetrahedron 2008; 64: 10465
19 Allen AD, Tidwell TT. Eur. J. Org. Chem. 2012; 1081
20 Sheibani H, Islami MR, Khabazzadeh H, Saidi K. Tetrahedron 2004; 60: 5931
21 Shao P, Chen X, Sun L, Ye S. Tetrahedron Lett. 2010; 51: 2316
22 Qi H, Zhang J, Xu J. Synthesis 2011; 887
23 Austin WF, Zhang Y, Danheiser RL. Tetrahedron 2008; 64: 915
24 Stadler A, Zangger K, Belaj F, Kollenz G. Tetrahedron 2001; 57: 6757
25 Du W, Truong Q, Qi H, Guo Y, Chobanian HR, Hagmann WK, Hale JJ. Tetrahedron Lett. 2007; 48: 2231
26 Bell K, Sadasivam DV, Gudipati IR, Ji H, Birney D. Tetrahedron Lett. 2009; 50: 1295
27 Fu N, Tidwell TT. Tetrahedron 2008; 64: 10465
28 Clemens RJ, Hyatt JA. J. Org. Chem. 1985; 50: 2431
29 Hyatt JA, Feldman PL, Clemens RJ. J. Org. Chem. 1984; 49: 5105
30 General Procedure for the Synthesis of Compounds 4 and 6A solution of aryl(alkyl)hydrazine (1 mmol) and aldehydes 2 (1.2 mmol) was stirred in toluene (5 mL) for 10 min. Then, 3 (0.19 g, 1.3 mmol) was added, irradiated under microwave at 900 W. After completion of the reaction [about 1 h; TLC monitoring (EtOAc–hexane, 1: 5)], the solvent was evaporated, and the residue was purified by column chromatography [silica gel (230–400 mesh; Merck), EtOAc–hexane, 1:5] to give pure product.4-Acetyl-2,5-diphenylpyrazolidin-3-one (4a)Yellow powder; mp 124–126 °C; yield: 0.23 g (83%). IR (KBr): 3384, 3051, 2923, 1691, 1618, 1500, 1457 cm^–1. ¹H NMR (500.1 MHz, CDCl₃): δ = 2.51 (3 H, s, Me), 3.96 (1 H, d, ³ J = 4.4 Hz, CH), 5.17 (1 H, d, ³ J = 4.4 Hz, CH), 5.35 (1 H, br s, NH), 7.18 (1 H, d, ³ J = 7.4 Hz, CH), 7.33–7.37 (2 H, m, CH), 7.39 (2 H, t, ³ J = 8.0 Hz, CH), 7.48 (2 H, d, ³ J = 7.9 Hz, CH), 7.58 (1 H, m, CH),7.92 (2 H, d, ³ J = 7.8 Hz, CH) ppm. ¹³C NMR (125.7 MHz, CDCl₃): δ = 29.7 (Me), 58.2 (CH), 66.2 (CH), 124.9 (2 CH), 125.9 (2 CH), 126.8 (C), 128.1 (CH), 128.5 (CH), 128.9 (2 CH), 129.0 (2 CH), 132.9 (C), 138.9 (C), 165.5 (C), 201.7 (C) ppm. MS (EI): m/z (%) = 280 (24) [M⁺], 278 (80), 263 (59), 91 (25), 77 (52). Anal. Calcd for C₁₇H₁₆N₂O₂ (280.32): C, 72.84; H, 5.75; N, 9.99. Found: C, 72.39; H, 5.84; N, 10.08.4-Acetyl-2-phenyl-5-p-tolylpyrazolidin-3-one (4b)Yellow powder; mp 123–125 °C; yield: 0.24 g (82%). IR (KBr): 3395, 3032, 2919, 1685, 1619, 1505 cm^–1. ¹H NMR (500.1 MHz, CDCl₃): δ = 2.34 (3 H, s, Me), 2.50 (3 H, s, Me), 3.96 (1 H, d, ³ J = 4.6 Hz, CH), 5.12 (1 H, d, ³ J = 4.6 Hz, CH), 5.23 (1 H, br s, NH), 7.16–7.19 (3 H, m, CH), 7.24 (2 H, d, ³ J = 8.0 Hz, CH), 7.38 (2 H, d, ³ J = 7.7 Hz, CH), 7.91 (2 H, d, ³ J = 8.0 Hz, CH) ppm. ¹³C NMR (125.7 MHz, CDCl₃): δ = 21.1 (Me), 29.7 (Me), 58.2 (CH), 66.0 (CH), 118.8 (2 CH), 120.9 (C), 124.6 (CH), 126.1 (2 CH), 128.9 (2 CH), 129.8 (2 CH), 138.0 (C), 138.4 (C), 165.7 (C), 201.8 (C) ppm. MS (EI): m/z (%) = 294 (14) [M⁺], 292 (80), 277 (58), 91 (43), 77 (24). Anal. Calcd for C₁₈H₁₈N₂O₂(294.35): C, 73.45; H, 6.16; N, 9.52. Found: C, 73.78; H, 6.07; N, 9.57.4-Acetyl-5-(2-chlorophenyl)-2-phenylpyrazolidin-3-one (4c)Yellow powder; mp 113–115 °C; yield: 0.27 g (85%). IR (KBr): 3424, 3059, 2924, 1698, 1625, 1554, 1497 cm^–1. ¹H NMR (500.1 MHz, CDCl₃): δ = 2.53 (3 H, s, Me), 3.85 (1 H, d, ³ J = 3.2 Hz, CH), 5.30 (1 H, d, ³ J = 3.2 Hz, CH), 5.38 (1 H, br s, NH), 7.19–7.25 (3 H, m, CH), 7.38 (2 H, d, ³ J = 6.5 Hz, CH), 7.42–7.47 (2 H, m, CH), 8.01 (2 H, d, ³ J = 7.9 Hz, CH) ppm. ¹³C NMR (125.7 MHz, CDCl₃): δ = 31.9 (Me), 56.0 (CH), 66.3 (CH), 118.1 (2 CH), 124.9 (CH), 127.0 (CH), 127.4 (CH), 129.0 (2 CH), 129.1 (CH), 129.8 (CH), 131.8 (C), 137.3 (C), 138.2 (C), 165.0 (C), 201.8 (C) ppm. MS (EI): m/z (%) = 314 (15) [M⁺], 312 (55), 297 (35), 91 (15), 77 (63). Anal. Calcd for C₁₇H₁₅ClN₂O₂(314.77): C, 64.87; H, 4.80; N, 8.90. Found: C, 65.15; H, 4.74; N, 9.01.X-ray Crystal-Structure Determination of 4c – Structure-Determination and Refinement DataFormula: C₁₇H₁₅ClN₂O₂; M _r 314.76; triclinic, space group: P1, a = 9.863(1), b = 10.850(1), c = 15.029(2) Å, α = 94.69(1)°, δ = 90.35(1)°, γ = 96.32(1)°; Z = 2, V = 1593.0(3) Å³, D _calcd = 1.312 mg/m³; Mo-Kα radiation (0.71073 Å); T = 293(2) K. 6580 reflections collected on a Bruker P4 diffractometer, 5545 unique (R _int = 0.0284). All heavy atoms have been located by difference Fourier maps and refined anisotropically. All hydrogen atoms except that of the NH group have been placed on calculated positions and refined isotropically by using the riding model. The NH proton has been located by difference Fourier maps and refined isotropically. Final indices for 2287 reflections with I > 2σ(Ι): R1 = 0.0588, wR2 = 0.1142, GOF = 1.008. The crystallographic data of 4c have been deposited with the Cambridge Crystallographic Data Centre as supplementary publication number CCDC 912090. Copies of the data can be obtained, free of charge, via the internet (http://www.ccdc.cam.ac.uk/data_request/cif), e-mail (data_request@ccdc.cam.ac.uk), or fax [+44(1223)336033].4-Acetyl-5-(3-chlorophenyl)-2-phenylpyrazolidin-3-one (4d)Yellow powder; mp 118–120 °C; yield: 0.25 g (81%). IR (KBr): 3421, 3063, 2922, 1695, 1593, 1497 cm^–1. ¹H NMR (500.1 MHz, CDCl₃): δ = 2.53 (3 H, s, Me), 3.92 (1 H, d, ³ J = 3.7 Hz, CH), 5.14 (1 H, d, ³ J = 3.7 Hz, CH), 5.27 (1 H, br s, NH), 7.19 (1 H, d, ³ J = 7.5 Hz, CH), 7.23–7.26 (2 H, m, CH), 7.28 (2 H, d, ³ J = 7.3 Hz, CH), 7.40 (2 H, t, ³ J = 7.7 Hz, CH), 7.94 (2 H, t, ³ J = 8.7 Hz, CH) ppm. ¹³C NMR (125.7 MHz, CDCl₃): δ = 30.4 (Me), 57.8 (CH), 66.7 (CH), 119.0 (2 CH), 124.3 (CH), 125.6 (CH), 126.8 (CH), 128.8 (CH), 129.5 (2 CH), 130.9 (CH), 135.3 (C), 138.6 (C), 141.7 (C), 165.3 (C), 201.9 (C) ppm. MS (EI): m/z (%) = 314 (27) [M⁺], 312 (80), 297 (57), 91 (23), 77 (48). Anal. Calcd for C₁₇H₁₅ClN₂O₂ (314.77): C, 64.87; H, 4.80; N, 8.90. Found: C, 64.63; H, 4.86; N, 9.00.4-Acetyl-5-(4-chlorophenyl)-2-phenylpyrazolidin-3-one (4e)Yellow powder; mp 105–107 °C; yield: 0.26 g (84%). IR (KBr): 3415, 3051, 2930, 1701, 1580 cm^–1. ¹H NMR (500.1 MHz, CDCl₃): δ = 2.53 (3 H, s, Me), 3.88 (1 H, d, ³ J = 3.4 Hz, CH), 5.13 (1 H, d, ³ J = 3.4 Hz, CH), 5.21 (1 H, br s, NH), 7.18 (1 H, d, ³ J = 7.3 Hz, CH), 7.28 (2 H, d, ³ J = 8.5 Hz, CH), 7.32 (2 H, d, ³ J = 8.5 Hz, CH), 7.39 (2 H, d, ³ J = 8.0 Hz, CH), 7.90 (2 H, d, ³ J = 8.0 Hz, CH) ppm. ¹³C NMR (125.7 MHz, CDCl₃): δ = 29.6 (Me), 57.4 (CH), 66.3 (CH), 118.5 (2 CH), 125.1 (CH), 127.2 (2 CH), 128.8 (2 CH), 129.1 (2 CH), 130.7 (C), 138.2 (C), 138.2 (C), 165.7 (C=O), 201.4 (C=O) ppm. MS (EI): m/z (%) = 314 (27) [M⁺], 312 (78), 297 (61), 91 (27), 77 (53). Anal. Calcd for C₁₇H₁₅ClN₂O₂ (314.77): C, 64.87; H, 4.80; N, 8.90. Found: C, 64.57; H, 4.89; N, 9.02.4-Acetyl-5-(3-nitrophenyl)-2-phenylpyrazolidin-3-one (4f)Yellow powder; mp 137–139 °C; yield: 0.31 g (94%). IR (KBr): 3415, 3080, 1704, 1619, 1532 cm^–1. ¹H NMR (500.1 MHz, CDCl₃): δ = 2.55 (3 H, s, Me), 3.92 (1 H, d, ³ J = 3.5 Hz, CH), 5.26 (1 H, br s, NH), 5.30 (1 H, d, ³ J = 3.5 Hz, CH), 7.19 (1 H, t, ³ J = 7.4 Hz, CH), 7.42 (2 H, t, ³ J = 7.3 Hz, CH), 7.53 (1 H, t, ³ J = 7.9 Hz, CH), 7.72 (1 H, d, ³ J = 7.7 Hz, CH), 7.91 (2 H, d, ³ J = 7.6 Hz, CH), 8.15 (1 H, d, ³ J = 8.0 Hz, CH), ppm. ¹³C NMR (125.7 MHz, CDCl₃): δ = 29.7 (Me), 57.0 (CH), 66.4 (CH), 118.4 (2 CH), 121.3 (CH), 123.0 (CH), 125.3 (CH), 129.3 (2 CH), 130.0 (CH), 132.1 (CH), 137.9 (C), 141.6 (C), 148.6 (C), 164.4 (C), 201.0 (C) ppm. MS (EI): m/z (%) = 325 (5) [M⁺], 323 (75), 308 (55), 308 (61), 91 (51), 77 (55). Anal. Calcd for C₁₇H₁₅N₃O₄(325.32): C, 62.76; H, 4.65; N, 12.92. Found: C, 63.07; H, 4.71; N, 13.04.4-Acetyl-5-(4-nitrophenyl)-2-phenylpyrazolidin-3-one (4g)Yellow powder; mp 156–158 °C; yield: 0.30 g (93%). IR (KBr): 3418, 3067, 2923, 1702, 1602, 1520 cm^–1. ¹H NMR (500.1 MHz, CDCl₃): δ = 2.53 (3 H, s, Me), 3.86 (1 H, d, ³ J = 2.8 Hz, CH), 5.14 (1 H, t, ³ J = 2.8 Hz, CH), 5.42 (1 H, br s, NH), 7.19 (1 H, t, ³ J = 7.4 Hz, CH), 7.40 (2 H, t, ³ J = 7.7 Hz, CH), 7.54 (2 H, d, ³ J = 8.5 Hz, CH), 7.90 (2 H, d, ³ J = 8.0 Hz, CH), 8.18 (2 H, d, ³ J = 8.7 Hz, CH) ppm. ¹³C NMR (125.7 MHz, CDCl₃): δ = 29.6 (Me), 57.1 (CH), 66.5 (CH), 118.4 (2 CH), 124.0 (2 CH), 125.3 (CH), 127.0 (2 CH), 129.0 (2 CH), 130.4 (C), 138.0 (C),146.7 (C), 164.4 (C), 200.9 (C) ppm. MS (EI): m/z (%) = 325 (14) [M⁺], 323 (80), 308 (55), 91 (22), 77 (57). Anal. Calcd for C₁₇H₁₅N₃O₄ (325.32): C, 62.76; H, 4.65; N, 12.92. Found: C, 62.58; H, 4.72; N, 12.98.4-Acetyl-5-(naphthalen-1-yl)-2-phenylpyrazolidin-3-one (4h)Pale yellow powder; mp 115–117 °C; yield: 0.26 g (80%). IR (KBr): 3424, 3230, 2923, 1668, 1606, 1549, 1497 cm^–1. ¹H NMR (500.1 MHz, CDCl₃): δ = 2.55 (3 H, s, Me), 3.93 (1 H, d, ³ J = 2.9 Hz, CH), 5.43 (1 H, br s, NH), 5.87 (1 H, d, ³ J = 2.9 Hz, CH), 7.20 (1 H, t, ³ J = 7.5 Hz, CH), 7.40–7.45 (3 H, m, CH), 7.52 (2 H, t, ³ J = 7.6 Hz, CH), 7.59 (1 H, d, ³ J = 7.2 Hz, CH), 7.70 (1 H, d, ³ J = 7.3 Hz, CH), 7.80 (1 H, d, ³ J = 7.5 Hz, CH), 7.90 (1 H, d, ³ J = 7.6 Hz, CH), 8.03 (2 H, d, ³ J = 7.2 Hz, CH) ppm. MS (EI): m/z (%) = 330 (6) [M⁺], 328 (77), 313 (62), 91 (14), 77 (33). Anal. Calcd for C₂₁H₁₈N₂O₂ (330.38): C, 76.34; H, 5.49; N, 8.48. Found: C, 76.69; H, 5.55; N, 8.57. N-Methyl-N′-[1-(4-methylphenyl)methylidene]-3-oxobutanohydrazide (6a)Pale yellow powder; mp 82–84 °C; yield: 0.18 g (77%). IR (KBr): 3430, 2924, 2857, 1687, 1607 cm^–1. ¹H NMR (500.1 MHz, CDCl₃): δ = 2.26 (3 H, s, Me), 2.37 (3 H, s, Me), 3.39 (3 H, s, CH₃N), 3.93 (2 H, s, CH₂), 7.19 (2 H, d, ³ J = 8.0 Hz, CH), 7.50 (2 H, d, ³ J = 8.0 Hz, CH), 7.66 (1 H, s, CH) ppm. ¹³C NMR (125.7 MHz, CDCl₃): δ = 21.4 (Me), 27.7 (Me), 29.9 (CH₃N), 50.4 (CH₂), 125.6 (C), 127.0 (2 CH), 128.5 (2 CH), 131.5 (C), 140.3 (CH), 168.9 (C), 202.0 (C) ppm. MS (EI): m/z (%) = 232 (18) [M⁺], 148 (55), 91 (28), 84 (80), 77 (10), 51 (55). Anal. Calcd for C₁₃H₁₆N₂O₂ (232.28): C, 67.22; H, 6.94; N, 12.06. Found: C, 66.89; H, 6.97; N, 12.15. N-Methyl-N′-[1-(4-nitrophenyl)methylidene]-3-oxobutanohydrazide (6b)Pale yellow powder; mp 156–158 °C; yield: 0.25 g (95%). IR (KBr): 3425, 2930, 1687, 1607 cm^–1. ¹H NMR (500.1 MHz, CDCl₃): δ = 2.27 (3 H, s, Me), 3.43 (3 H, s, CH₃N), 3.97 (2 H, s, CH₂), 7.66 (2 H, d, ³ J = 7.1 Hz, CH), 8.27 (2 H, d, ³ J = 7.1 Hz, CH) ppm. ¹³C NMR (125.7 MHz, CDCl₃): δ = 28.1 (Me), 29.9 (CH₃N), 50.4 (CH₂), 124.2 (2 CH), 127.6 (2 CH), 140.2 (C), 148.2 (C), 169.0 (C), 201.4 (C) ppm. MS (EI): m/z (%) = 263 (13) [M⁺], 136 (25), 91 (21), 77 (11). Anal. Calcd for C₁₂H₁₃N₃O₄ (263.2): C, 54.75; H, 4.98; N, 15.96. Found: C, 55.03; H, 5.06; N, 16.08. N′-[1-(4-Chlorophenyl)methylidene)]-N-(4-methyl-phenyl)-3-oxobutanohydrazide (6c)Yellow solid; mp 94–96 °C; yield: 0.21 g (67%). IR (KBr): 3435, 2920, 2861, 1701, 1607 cm^–1. ¹H NMR (500.1 MHz, CDCl₃): δ = 2.33 (3 H, s, Me), 2.43 (3 H, s, Me), 4.06 (2 H, s, CH₂), 7.08 (2 H, d, ³ J = 7.9 Hz, CH), 7.21 (1 H, s, CH), 7.33 (2 H, d, ³ J = 8.1 Hz, CH), 7.36 (2 H, d, ³ J = 7.9 Hz, CH), 7.43 (2 H, d, ³ J = 8.1 Hz, CH) ppm. MS (EI): m/z (%) = 328 (3) [M⁺], 271 (21), 77 (13). Anal. Calcd for C₁₈H₁₇ClN₂O₂ (328.80): C, 65.75; H, 5.21; N, 8.52. Found: C, 65.38; H, 5.28; N, 8.61. N′-[1-(3-Nitrophenyl)methylidene)]-N-(4-methyl-phenyl)-3-oxobutanohydrazide (6d)Yellow solid; mp 105–107 °C; yield 0.24 g (71%). IR (KBr): 3425, 2930, 1687, 1607 cm^–1. ¹H NMR (500.1 MHz, CDCl₃): δ = 2.40 (3 H, s, Me), 2.54 (1 H, d, ³ J = 3.5 Hz, CH), 2.95 (2 H, s, CH₂), 7.41–45 (2 H, m, CH), 7.16 (1 H, s, CH), 7.65 (1 H, d, ³ J = 7.6 Hz, CH), 7.83 (2 H, d, ³ J = 7.6 Hz, CH), 8.30 (1 H, d, ³ J = 7.6 Hz, CH) ppm. MS (EI): m/z (%) = 339 (4) [M⁺], 282 (14), 77 (11). Anal. Calcd for C₁₈H₁₇N₃O₄ (339.35): C, 63.71; H, 5.05; N, 12.38. Found: C, 63.96; H, 5.08; N, 12.46.
31 Burnett AM. N, Johnson CK Oak Ridge National Laboratory Report ORNL-6895, Oak Ridge National Laboratory: Oak Ridge, 1996
32 Frisch MJ, Trucks GW, Schlegel HB, Scuseria GE, Robb MA, Cheeseman JR, Scalmani G, Barone V, Mennucci B, Petersson GA, Nakatsuji H, Caricato M, Li X, Hratchian HP, Izmaylov AF, Bloino J, Zheng G, Sonnenberg JL, Hada M, Ehara M, Toyota K, Fukuda R, Hasegawa J, Ishida M, Nakajima T, Honda Y, Kitao O, Nakai H, Vreven T, Montgomery JA. Jr, Peralta JE, Ogliaro F, Bearpark M, Heyd JJ, Brothers E, Kudin KN, Staroverov VN, Kobayashi R, Normand J, Raghavachari K, Rendell A, Burant JC, Iyengar SS, Tomasi J, Cossi M, Rega N, Millam JM, Klene M, Knox JE, Cross JB, Bakken V, Adamo C, Jaramillo J, Gomperts R, Stratmann RE, Yazyev O, Austin AJ, Cammi R, Pomelli C, Ochterski JW, Martin RL, Morokuma K, Zakrzewski VG, Voth GA, Salvador P, Dannenberg JJ, Dapprich S, Daniels AD, Farkas O, Foresman JB, Ortiz JV, Cioslowski J, Fox DJ Gaussian 09, Revision A.02, Gaussian, Inc.: Wallingford, 2009

A Diastereoselective Synthesis of Functionalized 3-Pyrazolidinones from ­Hydrazines, Aromatic Aldehydes, and Acylketene

Autoren

A Diastereoselective Synthesis of Functionalized 3-Pyrazolidinones from Hydrazines, Aromatic Aldehydes, and Acylketene